Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 6.83
-8.69 %
$ 370 M
Market Cap
-1.75
P/E
EBS - TOTAL RECEIVABLES
Total Receivables EBS - Emergent BioSolutions Inc.
191 M
LAST VALUE
-17.25%
2 YEAR CAGR
-6.16%
5 YEAR CAGR
11.17%
10 YEAR CAGR